(Z)-1,3,3,3-tetrafluoroprop-1-ene

Endpoint summary

Description of key information

Skin sensitisation (in vivo): Not sensitising (QSAR, Weight of Evidence)

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Reference

Reference 1

Endpoint:

skin sensitisation, other

Remarks:

QSAR result

Type of information:

(Q)SAR

Adequacy of study:

weight of evidence

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

results derived from a valid (Q)SAR model, but not (completely) falling into its applicability domain, with adequate and reliable documentation / justification

Guideline:

other: REACH Guidance on QSARs R.6

Principles of method if other than guideline:

Model developer(s) and contact details:
[1] Qasim Chaudhry Food & Environment Research Agency, Sand Hutton, York
[e-mail]
[2] Nadège Piclin BioChemics Consulting, 111 Bld. Duhamel du Monceau
[e-mail]
[3] Jane Cotterill Food & Environment Research Agency, Sand Hutton, York
[e-mail]
[4] Marco Pintore BioChemics Consulting, 111 Bld. Duhamel du Monceau
[e-mail]
[5] Nick R Price Food & Environment Research Agency, Sand Hutton, York
[e-mail]
[6] Jacques R Chrétien BioChemics Consulting, 111 Bld. Duhamel du Monceau
[e-mail]
[7] Alessandra Roncaglioni IRCCS - Istituto di Ricerche Farmacologiche Mario Negri
[e-mail]

Reference(s) to main scientific papers and/or software package:
Chaudhry, Q., Piclin, N., Cotterill, J., Pintore, M., Price, N. R., Chrétien, J. R. and Roncaglioni, A. (2010). Global QSAR models of skin sensitisers for regulatory purposes., Chem Cent J 4 Suppl 1, S5.

Availability of information about the model:
Available through the VEGA software, free download of software is possible on VEGA website. The training, test and validation sets are also available

Endpoint:
QMRF 4.6. Skin sensitisation. Skin sensitisation on mouse (local lymph node assay model) OECD 429.

Specific details on test material used for the study:

C(=C\F)\C(F)(F)F

Parameter:

other: QSAR

Test group / Remarks:

QSAR

Remarks on result:

no indication of skin sensitisation based on QSAR/QSPR prediction

Interpretation of results:

GHS criteria not met

Conclusions:

Skin CAESAR Model version 2.1.6 predicts the substance is a NON-SENSITISER.

Executive summary:

The present software provides the result indicating lack of effect for skin sensitization. However, this result is only based on the descriptors and cannot be supported by the evidence from the presence of structurally similar compounds. Thus, there is a high level of uncertainty.

To reduce this uncertainty, the results of this model have to be supported by other lines of evidence. In our case we also a second model present in VEGA, to increase reliability, and we also verified if on a mechanistic basis there were reasons indicating possible sensitization. For the mechanistic basis we used the OECD QSAR Toolbox. The OECD QSAR Toolbox reports that there is no alert found for Protein bonding by OASIS. In a previous study done by JRC (Mr David Asturiol) in collaboration with Istituto Mario Negri (Mrs Serena Manganelli) this profiler was the best one, compared with other profilers for skin sensitization present within the OECD QSAR Toolbox ( Internal data). To support the results of the QSAR model, the OECD QSAR Toolbox identifies for the target substance the possibility of SN2 according to the Protein binding by OECD. However, the energy of the binding between C and F is quite high, and the plausibility that this reaction occurs at the body temperature is quite limited.

Overall, considering that there are two QSAR models indicating lack of effect, and that the OECD QSAR Toolbox is aligned with the same conclusion on a mechanistic basis, as indicated by the OASIS profiler, these joined lines of evidence support the call for lack of skin sensitization.

Reference 2

Endpoint:

skin sensitisation, other

Remarks:

QSAR result

Type of information:

(Q)SAR

Adequacy of study:

weight of evidence

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

results derived from a valid (Q)SAR model, but not (completely) falling into its applicability domain, with adequate and reliable documentation / justification

Guideline:

other: REACH Guidance on QSARs R.6

Specific details on test material used for the study:

C(=C\F)\C(F)(F)F

Parameter:

other: QSAR

Test group / Remarks:

QSAR

Remarks on result:

no indication of skin sensitisation based on QSAR/QSPR prediction

Interpretation of results:

GHS criteria not met

Conclusions:

Skin Sensitization model (IRFMN/JRC) 1.0.0 predicts the substance is a NON-SENSITISER.

Executive summary:

The present software provides the result indicating lack of effect for skin sensitization. However, this result is only based on the descriptors and cannot be supported by the evidence from the presence of structurally similar compounds. Thus, there is a high level of uncertainty.

To reduce this uncertainty, the results of this model have to be supported by other lines of evidence. In our case we also a second model present in VEGA, to increase reliability, and we also verified if on a mechanistic basis there were reasons indicating possible sensitization. For the mechanistic basis we used the OECD QSAR Toolbox. The OECD QSAR Toolbox reports that there is no alert found for Protein bonding by OASIS. In a previous study done by JRC (Mr David Asturiol) in collaboration with Istituto Mario Negri (Mrs Serena Manganelli) this profiler was the best one, compared with other profilers for skin sensitization present within the OECD QSAR Toolbox ( Internal data). To support the results of the QSAR model, the OECD QSAR Toolbox identifies for the target substance the possibility of SN2 according to the Protein binding by OECD. However, the energy of the binding between C and F is quite high, and the plausibility that this reaction occurs at the body temperature is quite limited.

Overall, considering that there are two QSAR models indicating lack of effect, and that the OECD QSAR Toolbox is aligned with the same conclusion on a mechanistic basis, as indicated by the OASIS profiler, these joined lines of evidence support the call for lack of skin sensitization.

Endpoint conclusion

Endpoint conclusion:

no study available

Additional information:

Skin sensitisation:

Two VEGA QSAR models (Skin CAESAR Model version 2.1.6 and Skin Sensitization model (IRFMN/JRC) 1.0.0) based on the LLNA in mice were available and were used in a weight of evidence approach.

The Skin CAESAR Model version 2.1.6 model provides the result indicating lack of effect for skin sensitization. However, this result is only based on the descriptors and cannot be supported by the evidence from the presence of structurally similar compounds. Thus, there is a high level of uncertainty. To reduce this uncertainty, the results of this model have to be supported by other lines of evidence. In our case we also a second model present in VEGA (Skin Sensitization model (IRFMN/JRC) 1.0.0), to increase reliability, and we also verified if on a mechanistic basis there were reasons indicating possible sensitization. For the mechanistic basis we used the OECD QSAR Toolbox. The OECD QSAR Toolbox reports that there is no alert found for Protein bonding by OASIS. In a previous study done by JRC (Mr David Asturiol) in collaboration with Istituto Mario Negri (Mrs Serena Manganelli) this profiler was the best one, compared with other profilers for skin sensitization present within the OECD QSAR Toolbox (Internal data). To support the results of the QSAR model, the OECD QSAR Toolbox identifies for the target substance the possibility of SN2 according to the Protein binding by OECD. However, the energy of the binding between C and F is quite high, and the plausibility that this reaction occurs at the body temperature is quite limited.

Overall, considering that there are two QSAR models indicating lack of effect, and that the OECD QSAR Toolbox is aligned with the same conclusion on a mechanistic basis, as indicated by the OASIS profiler, these joined lines of evidence support the call for lack of skin sensitization.

Respiratory sensitisation

Endpoint conclusion

Endpoint conclusion:

no study available

Justification for classification or non-classification

Based on the available information in the dossier, (1Z)-1,3,3,3-Tetrafluoroprop-1-ene (CAS No. 29118-25-0) does not need to be classified for skin sensitisation when the criteria outlined in Annex I of 1272/2008/EC and Annex I of 286/2011/EC are applied.